Begin main content

We're hosting a series of lectures by prominent scholars and opinion leaders to share their perspectives on some of the most pressing issues facing health technology assessment (HTA) today.

Upcoming Sessions:

Gene Therapy: A Scientific Renaissance? 

Tuesday, February 27, 2018

Matthew Seftel, MD, MPH, FRCP, FRCPC
Head, Department of Medical Oncology and Hematology, CancerCare Manitoba
Associate Professor, Section of Hematology/Oncology, Department of Internal Medicine, University of Manitoba. 

For diseases caused by inherited or acquired genetic mutations, the ideal remedy is to correct the relevant mutations. Recently, promising results have emerged about gene therapy for patients with inherited conditions as well as in patients with acquired hematological malignancies, with positive results for the latter being obtained by infusing chimeric antigen receptor T-cell therapy (CART). Using CART as the most prominent example of gene therapy, this talk will provide a background to gene therapy and to blood and marrow transplantation. Dr. Seftel will summarize the available data about CART therapy and will also outline the clinical, economic, and regulatory challenges associated with CART and other gene therapeutics.

The event is free of charge, but registration is required.

Date:  Tuesday, February 27, 2018
Lecture:  2:00 p.m. to 3:00 p.m. EST
Reception: 3:00 p.m. to 3:30 p.m. EST
In person: Dows Lake Court Conference Centre, 865 Carling Avenue, Ottawa.

More Information

Previous Sessions

If you missed out on a lecture or want a refresher on what you saw or heard, you can access information from previous sessions. If available, you will find copies of presentations and previously recorded webinars.

What Our Attendees Are Saying About Our Sessions

  • "Interesting, inspiring, and relevant."
  • "Intelligent, minimal jargon, so easy to follow, engaging."
  • "Such a delightful personality, with remarkable insight into her field; truly time well spent!"
  • "Very engaging speaker. Very knowledgeable. Great to get how HTA has evolved elsewhere in the world."

Tell Us What You Think

Have an idea for a speaker suited to our lecture series? Send us your suggestions.